<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0685">
 <label>137</label>
 <mixed-citation publication-type="other" id="or0180">Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS (COVID-19) Nanoparticle Vaccine With/Without Matrix-M Adjuvant - Full Text View - ClinicalTrials.gov, (n.d.). https://clinicaltrials.gov/ct2/show/NCT04368988 (accessed June 18, 2020).</mixed-citation>
</ref>
